Answers are grounded in this paper and cite their sources.
Dendrobium nobile Lindl. is an epiphytic perennial herbaceous medicinal plant belonging to the genus Dendrobium within the Orchidaceae family. It contains several pharmacologically active components, with dendrobine being the primary constituent. In this study, we aimed to investigate the transcriptional and metabolomic differences between two D. nobile samples exhibiting significantly distinct dendrobine content. The content analysis of the two D. nobile samples revealed that dendrobine content (0.962%) was significantly higher at the young shoot stage than at the vigorous stage (0.335%). Transcriptome and metabolome integrated analysis was employed to elucidate the molecular mechanisms underlying dendrobine biosynthesis. The transcriptome revealed 25,772 expressed genes, with 2075 showing significant differential expression. The metabolome revealed 7821 metabolites, identifying 383 differentially expressed metabolites primarily enriched in terpenoids, phenylpropanoids, and organic nitrogen compounds. The dynamic changes in dendrobine content correlated with the expression trends of key genes involved in terpenoid skeleton synthesis. Furthermore, the accumulation of sesquiterpene metabolites correlated with the high gene expression (e.g., FDPS and GGPPS1 ), indicating their roles in sesquiterpene biosynthesis. KEGG analysis revealed significant enrichment of the 'terpenoid backbone biosynthesis' pathway (false discovery rate <0.05), highlighting its pivotal role in supplying precursors for dendrobine biosynthesis. This study preliminarily revealed the molecular basis for dendrobine accumulation, identifying candidate genes and metabolic pathways, thus providing foundational data and theoretical support for subsequent functional validation and dendrobine biosynthesis.
No takes yet. Share an insight, caveat, or question.
梁增新 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: